BPC-157 is a stable 15-amino-acid fragment obtained from the protein of human gastric juice, while TB-500 is a synthetic variant of the active domain of Thymosin Beta-4
doi:10.1016/j.redox.2019.101223
Stylopoulos N, Gazelle GS, Rattner DW
The company states that each batch undergoes three separate rounds of testing at independent third-party laboratories: Testing Round 1 - Identity Verification: According to the company, this confirms the product contains actual BPC-157 rather than filler or substitute compounds, using analytical techniques like mass spectrometry to verify the molecular structure matches authentic BPC-157
Resources & Support Documentation, tools, and assistance for your research
[DOI] [PubMed] [Google Scholar] 163.Ertunc ME, Sikkeland J, Fenaroli F, Griffiths G, Daniels MP, Cao H, et al